Lake Street Capital assumed coverage on shares of Electromed (NYSE:ELMD – Get Rating) in a report released on Friday, Stock Target Advisor reports. The firm issued a buy rating and a $20.00 price objective on the stock.
Separately, StockNews.com initiated coverage on Electromed in a report on Monday, August 1st. They issued a strong-buy rating on the stock.
Electromed Trading Up 1.2 %
Shares of NYSE ELMD opened at $9.25 on Friday. The company has a market cap of $78.90 million, a price-to-earnings ratio of 35.58 and a beta of 0.59. Electromed has a 1 year low of $8.75 and a 1 year high of $13.85. The firm has a 50 day simple moving average of $10.03.
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.
- Get a free copy of the StockNews.com research report on Electromed (ELMD)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.